Literature DB >> 18033602

Botulinum toxin treatment of axial and cervical dystonia.

Reiner Benecke1, Dirk Dressler.   

Abstract

Axial truncal dystonia is characterized by an abnormal trunk posture often superimposed by myoclonic motor activities. Cervical dystonia is a motor syndrome characterized by abnormal head and neck posture due to tonic involuntary contractions in a certain set of muscles often superimposed by myoclonic or tremulous movements. Intramuscular injection of botulinum toxin is the first line treatment in cervical dystonia, in axial truncal dystonias botulinum toxin therapy is used only in mild forms. In this review the theoretical background, practical aspects and efficacy results especially in cervical dystonia are presented. Treatment of axial trunk dystonia is only briefly discussed at the beginning of this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033602     DOI: 10.1080/01421590701568262

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  11 in total

Review 1.  Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

2.  Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.

Authors:  Andrea Santamato; Maurizio Ranieri; Francesco Panza; Stefano Zoccolella; Vincenza Frisardi; Vincenzo Solfrizzi; Maria Teresa Amoruso; Loredana Amoruso; Pietro Fiore
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

3.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

4.  Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations.

Authors:  M Brown; G Nicholson; M C Ardila; A Satorius; R S Broide; K Clarke; T Hunt; J Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-07-29       Impact factor: 3.575

5.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

6.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

7.  [Botulinum toxin treatment : therapy success in cases of depression and ongoing pension applications].

Authors:  A Bachhuber; G Reichel; M Doberenz; A Stenner; W Hermann
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 8.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

9.  Botulinum toxin therapy for cervical dystonia: the science of dosing.

Authors:  Virgilio Gerald H Evidente; Eric J Pappert
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-11-12

10.  Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach.

Authors:  Kantharuby Tambirajoo; Luciano Furlanetti; Michael Samuel; Keyoumars Ashkan
Journal:  Front Hum Neurosci       Date:  2021-06-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.